Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,091 hedge funds and large institutions have $64B invested in Allergan plc in 2016 Q4 according to their latest regulatory filings, with 166 funds opening new positions, 323 increasing their positions, 511 reducing their positions, and 158 closing their positions.
8% more call options, than puts
Call options by funds: $4.55B | Put options by funds: $4.23B
5% more first-time investments, than exits
New positions opened: 166 | Existing positions closed: 158
1% less funds holding
Funds holding: 1,105 → 1,091 (-14)
16% less capital invested
Capital invested by funds: $75.9B → $64B (-$11.8B)
17% less funds holding in top 10
Funds holding in top 10: 107 → 89 (-18)
37% less repeat investments, than reductions
Existing positions increased: 323 | Existing positions reduced: 511
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AL
Appaloosa LP
Short Hills,
New Jersey
|
+$630M |
| 2 |
Edgewood Management
Greenwich,
Connecticut
|
+$523M |
| 3 |
Legal & General Group
London,
United Kingdom
|
+$348M |
| 4 |
BG
Baupost Group
Boston,
Massachusetts
|
+$296M |
| 5 |
ETC
Evercore Trust Company
New York
|
+$270M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TP
Third Point
New York
|
-$872M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$711M |
| 3 |
Jennison Associates
New York
|
-$561M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$518M |
| 5 |
Lazard Asset Management
New York
|
-$445M |
AGN Hedge Fund Activity: Q4 2016 in Review
1,091 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q4 2016, worth a combined $64B — down 16% from $75.9B a quarter earlier.
Buyers outnumbered sellers: 166 funds opened new AGN positions and 158 closed out — a net gain of 8 holders — while 323 added to existing stakes and 511 trimmed.
The largest buyer was Appaloosa LP, adding an estimated $630M. The largest seller was Third Point, exiting entirely with an estimated $872M sold.
- 1,091 institutional investors held Allergan plc (AGN) as of Q4 2016, down from 1,105 in Q3 2016.
- Funds reported $64B of Allergan plc stock for Q4 2016, down 16% quarter-over-quarter.
- 166 funds opened new Allergan plc positions in Q4 2016 and 158 closed out, a net change of +8 holders.
- The largest Allergan plc buyer in Q4 2016 was Appaloosa LP, an estimated $630M added.
- The largest Allergan plc seller in Q4 2016 was Third Point, an estimated $872M sold.
Based on aggregated 13F filings for Q4 2016.